Devsecops for healthcare let the pipeline file the proof
Devsecops for healthcare let the pipeline file the proof

Share This Article

DevSecOps for Healthcare: Let the Pipeline File the Proof

A security scan that nobody can show to a regulator might as well never have run. That is the quiet failure inside many DevSecOps programs in life sciences: the work gets done, but the proof is scattered across tickets, screenshots, and one engineer’s memory.

Done well, DevSecOps for healthcare reverses that order. Instead of assembling proof before a submission, the build produces it every time it runs. At ITJ, we design delivery flows so that each commit, build, and test leaves behind a record someone can open months later without asking the author what happened.

What the FDA Actually Asks For

The agency’s current guidance on premarket cybersecurity, issued in February 2026, is specific about what a manufacturer must be able to show. The guidance explains that section 524B of the FD&C Act, in force since March 2023, requires an SBOM in applicable premarket submissions for cyber devices, a legal category that covers devices with software, the ability to connect to the internet, and characteristics that could be vulnerable to cybersecurity threats.

An SBOM is a formal record of the components used to build a piece of software. FDA recommends a machine-readable SBOM, supported by information about component support status, end-of-support dates, and known vulnerabilities. Not all of this supporting information has to be embedded in the SBOM itself, but manufacturers need it to assess exposure and plan remediation.

The guidance goes further than the list itself:

  • Known vulnerabilities: manufacturers should identify them, including those in CISA’s Known Exploited Vulnerabilities Catalog.
  • Response speed: track the time from identifying a vulnerability to releasing a patch, and from patch to deployment in the field.
  • Ongoing testing: repeat cybersecurity testing at regular intervals after release, with annual testing given as an example.

Notice what is missing. FDA encourages a secure product development framework, but it also says other approaches might satisfy the same expectations. It asks for evidence, not for a particular tool. Automating the record-keeping is our answer, not the agency’s rule. Taken together, these items describe a living file rather than a one-time attachment.

Five Stages, Five Pieces of Evidence

Think of the delivery flow as a chain in which every stage has one job: leave an artifact behind.

  • Commit stage: each change is tied to a requirement and reviewed by a second person. The artifact is a change record showing who wrote it, who approved it, and why.
  • Build stage: the SBOM is generated automatically every time the code is compiled, not rebuilt by hand at submission time. The artifact is a versioned component list, with support dates, for each release.
  • Test stage: dependency scans run against known vulnerability sources, and security tests run beside functional ones. The artifact is a findings report where each item has a disposition: fixed, mitigated, or not exploitable, with the reasoning written down.
  • Release stage: the signed release candidate, its SBOM, and its findings are archived together. The artifact is a single evidence package a reviewer can open without a tour.
  • Post-release stage: the stored SBOM is checked against new advisories, and the response clocks the guidance describes are measured, not estimated. The artifact is a vulnerability log with dates.

If a stage cannot name its artifact, that stage is exactly where a reviewer’s question will land. People still make the judgment calls, such as whether a finding is exploitable in a given device. Automation only guarantees that the record exists, is complete, and matches the release candidate it describes.

Why manual proof breaks down itj

Why Manual Proof Breaks Down

Manual assembly fails in a predictable way: the person who knew where everything lived has moved on, and the folder of screenshots is missing the one month someone asks about. The pressure is not theoretical either. Hacking and IT incidents accounted for 81% of the 663 breaches of 500 or more people reported to HHS for 2024. Business associates filed only 16% of those reports, yet roughly 85% of the affected individuals were tied to them.

That second number matters to anyone with outside engineering partners. A vendor that cannot show its own build evidence is a risk the manufacturer inherits. NIST adds a useful caution: an SBOM supplements vulnerability management and does not replace it. A list of components that nobody reviews is still just a list.

A Practical Place to Start

The easiest way into DevSecOps for healthcare is to start with one release, not the whole organization at once.

  • Trace one release backward: list what it would take to assemble the five artifacts for it today, and time the effort. The gap between that number and zero is the project.
  • Close gaps in order: automated SBOM generation first, since the guidance names it as required, then dispositions for every finding, then the response clocks.
  • Name a reviewer: evidence that nobody reads decays quickly, and a named owner keeps it honest.

Where a Nearshore Tech Team Fits

Evaluating nearshore software development Mexico solutions for a regulated product only works if the partner’s build evidence matches your regulatory standards. In our model, a remote software engineer in Mexico commits to the same repository, passes the same gates, and leaves the same records as anyone else on the team. The seat changes. The record does not.

That same delivery discipline matters when a regulated product connects to the wider technology environment. Testing can verify relevant interfaces with enterprise platforms such as SAP or Salesforce. The scope depends on the architecture, but each tested integration should leave a record tied to the specific release it was tested against.

The same habit extends to AI/ML work. Nearshore data science teams that train models inside the same delivery flow can record dataset and model versions next to the SBOM, so the whole product has a traceable history, not just its code. That goes beyond what FDA’s SBOM requirement asks. It is our practice, and we think it saves arguments later.

As a nearshore software engineering partner, we treat the compliance evidence package as a core deliverable alongside the codebase itself. Shared working hours mean security triage, audit preparation, and release reviews happen live with your internal compliance team.

Proof That Stays Yours

ITJ is ISO 27001 certified, and ITJ Solutions states that protected health information (PHI) and personally identifiable information (PII) in its engagements remain hosted in the United States. These measures support information security, but they do not replace the manufacturer’s own regulatory obligations or review process.

Start with one release. We can help you assess which cybersecurity artifacts your pipeline already produces, how those records are retained, and where manual work or missing evidence could slow down a review.

Go deeper:

About ITJ
ITJ is committed to catering to fast-growing and high-value markets, especially the Internet of Medical Things (IoMT), collaborating with innovative medical device companies aiming to enhance people’s lives.With a unique BOT model that sources the best digitaltalent, ITJ helps U.S. companies establish technology centers of excellence in LATAM.

For more information, visit itj.com.